WELLINGTON MANAGEMENT GROUP LLP - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 81 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$100,000
-95.9%
83,302
-94.8%
0.00%
-100.0%
Q3 2019$2,411,000
-60.0%
1,596,601
+6.4%
0.00%0.0%
Q2 2019$6,031,000
-6.5%
1,500,1270.0%0.00%0.0%
Q1 2019$6,451,000
-25.2%
1,500,1270.0%0.00%
-50.0%
Q4 2018$8,626,000
-57.6%
1,500,1270.0%0.00%
-50.0%
Q3 2018$20,342,000
+11.0%
1,500,127
-2.8%
0.00%0.0%
Q2 2018$18,320,000
+8.2%
1,543,366
+2.3%
0.00%0.0%
Q1 2018$16,934,000
+321.1%
1,507,965
+150.5%
0.00%
+300.0%
Q4 2017$4,021,000
-20.4%
601,878
-2.5%
0.00%0.0%
Q3 2017$5,053,000
+98.6%
617,003
+8.9%
0.00%0.0%
Q2 2017$2,544,000
-24.2%
566,553
-6.9%
0.00%0.0%
Q1 2017$3,354,000
+59.7%
608,633
+17.4%
0.00%0.0%
Q4 2016$2,100,000
-48.1%
518,523
-9.6%
0.00%0.0%
Q3 2016$4,045,000
-5.7%
573,723
+9.0%
0.00%0.0%
Q2 2016$4,288,000
-1.2%
526,123
-1.4%
0.00%0.0%
Q1 2016$4,339,000
-38.0%
533,643
-8.0%
0.00%
-50.0%
Q4 2015$6,997,000580,1730.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 5,555,461$4,405,4812.16%
MPM BioImpact LLC 5,095,912$4,041,0580.94%
NEA Management Company, LLC 17,079,778$13,544,6240.90%
Syncona Portfolio Ltd 1,377,294$1,092,1940.69%
PFM Health Sciences, LP 10,423,135$8,265,5460.50%
TANG CAPITAL MANAGEMENT LLC 4,387,238$3,479,0800.32%
Long Focus Capital Management, LLC 12,086,915$9,584,9240.32%
Matrix Capital Management Company, LP 38,974,185$30,906,5290.32%
Acuitas Investments, LLC 479,789$380,4730.20%
Key Client Fiduciary Advisors, LLC 336,620$266,9400.16%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders